Results 231 to 240 of about 47,536 (295)

Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure. [PDF]

open access: yesBiomolecules
Licordari R   +7 more
europepmc   +1 more source

Immune checkpoint inhibitor cardiomyotoxicity: a case series of five patients and development of a clinical management algorithm

open access: yesInternal Medicine Journal, EarlyView.
Abstract Immune checkpoint inhibitor (ICI) therapies have revolutionised the management of a range of malignancies. However, the syndrome of ICI induced cardiomyotoxicity, also reported as triple “M” syndrome (myasthenia gravis, myositis and myocarditis) is an unfortunate severe consequence in up to 1%–2% of patients receiving ICI, with an associated ...
S. Z. Xie   +14 more
wiley   +1 more source

Natriuretic Peptides to Classify Risk of Atrial Fibrillation Detection After Stroke: Analysis of the BIOSIGNAL and PRECISE Cohort Studies. [PDF]

open access: yesNeurology
Cameron AC   +21 more
europepmc   +1 more source

Differential processing of plasma-ANF in cardiovascular disease [PDF]

open access: yes, 1987
Arendt, Rainer M.   +4 more
core  

Clinical Prediction Model for Unsuccessful Left Bundle Branch Area Pacing

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
A clinical prediction model based on NIVCD, interventricular septal thickness, and right atrial area enables individualized estimation of unsuccessful LBBAP and may help guide procedural strategy. ABSTRACT Introduction Left bundle branch area pacing (LBBAP) has rapidly become a preferred form of cardiac physiologic pacing; however, predictors of ...
Yousaku Okubo   +13 more
wiley   +1 more source

Natriuretic peptides. Evolution of knowledge

open access: yesТерапевтический архив, 2003
О М Eliseev
doaj  

Comparison of troponin and natriuretic peptides in Takotsubo syndrome and acute coronary syndrome: a meta-analysis. [PDF]

open access: yesOpen Heart
Couch LS   +10 more
europepmc   +1 more source

Prospective Trial of Radiofrequency Catheter Ablation of High Dominant Frequencies After Pulmonary Vein Isolation in Non‐Paroxysmal Atrial Fibrillation (PAD‐AF Trial): A Multicenter, Randomized Clinical Trial

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
In persistent AF, adjunctive dominant frequency‐guided ablation after pulmonary vein isolation did not significantly improve outcomes. Limited overlap between high‐frequency sites and low‐voltage areas suggests functional–structural dissociation, while right atrial low‐voltage burden predicts recurrence.
Koji Kumagai   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy